MATILDE RODRIGUEZ SOTOMAYOR: Open Payments
NPI 1932203544 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,727 in 97 payments from 16 companies in 2025. Trend: 2023 $2,139 · 2024 $2,456 · 2025 $2,727
Food & beverage: $2,717Education: $10
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $525 |
| ABBVIE INC. | 19 | $495 |
| AstraZeneca Pharmaceuticals LP | 12 | $486 |
| Lilly USA, LLC | 10 | $168 |
| Astellas Pharma US Inc | 8 | $162 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $157 |
| Phathom Pharmaceuticals, Inc. | 3 | $131 |
| TG Therapeutics, Inc. | 1 | $125 |
| PFIZER INC. | 1 | $125 |
| Verona Pharma, Inc. | 3 | $92 |
Products named: JARDIANCE, Ozempic, FARXIGA, QULIPTA, Wegovy, Veozah, AIRSUPRA, BREZTRI.
Industry payments across PA — which companies pay providers there.
